Government inaugurated India’s first pneumococcal conjugate vaccine (PCV)

• Feb 21 CA
• Jan 21 CA
• Dec 20 CA
• Nov 20 CA
• Oct 20 CA
• Sep 20 CA
• Aug 20 CA
• Jul 20 CA
• Jun 20 CA
• May 20 CA

Daily Current Affairs Article 30th December 2020: Union Minister for Health and Family Welfare inaugurated India’s first pneumococcal conjugate vaccine (PCV). The vaccine “Pneumosil” has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melinda Gates Foundation.

SIIPL developed and got the license of the first indigenous Pneumococcal Conjugate Vaccine (PCV) from the Government of India during COVID-19 pandemic lock-down.

This Indigenous Pneumococcal Conjugate Vaccine will be available in the market under the brand name "Pneumosil" at an affordable price in a single dose (vial and pre-filled syringe) and Multidose (vial) presentations.

Pneumosil is effective in the prevention of Pneumonia disease.